The competition and their side effects, page-4

Your top-level comparison certainly paints a good picture for PPS. But I do think you’re being a bit too kind about opioids – even if you have described them negatively.

This is a quote from the RACGP (Royal Australian College of General Practice) - on the use of opioids in chronic non-cancer pain in 2013. A bit old – but Since then concerns have raised even more - as has prescribing of drugs like Targin, Oxycontin, Norspan etc which have gone through the roof. (I’ve added bold for emphasis)

"For chronic non-cancer pain, the evidence base for the long-term use of opiates is mediocre, with weak support for minimal improvements in pain measures and little or no evidence for functional restoration. Much research and professional education in this field has been underwritten by commercial interests. Escalating the prescribing of opioids has been repeatedly linked to a myriad of individual and public harms, including overdose deaths. Many patients on long-term opioids may never be able to taper off them, despite their associated toxicities and lack of efficacy."

(See https://www.racgp.org.au/afp/2013/march/opioid-use-part-1/)

If PPS can’t beat opioids then who can?